At least some of the large preponderance for coronary heart disease in men has been attributed to differences in lipid and lipoprotein levels; notably, high density lipoprotein cholesterol (HDL-C), a protective factor, is higher in women. The sex differences in lipid levels have been postulated to be related to differences in sex hormones. In a southern California cohort of 391 men aged 30-79 years, HDL-C levels were positively correlated and very low density lipoprotein cholesterol (VLDL-C) levels were inversely correlated with testosterone levels independently of age, body mass index, physical exercise, smoking, and alcohol intake. Mean HDL-C levels were 12% higher and VLDL-C levels were 40% lower in the highest compared with the lowest quartile of testosterone level. Low density lipoprotein cholesterol levels were positively related to estrone, estradiol, and androstenedione levels. It is premature to attribute the sex differential in lipid cardiovascular risk profiles to higher levels of testosterone per se in men, since testosterone levels are favorably associated with cardiovascular risk while estrogen levels have the converse relation ip men. The differing effects and interactions of specific endogenous sex hormones in men and women require further elucidation. (Arteriosclerosis and Thrombosis 1991;ll:489-494) T he large preponderance for coronary heart disease in men is well recognized. At least some of the sex differential has been attributed to differences in cardiovascular risk factor levels; notably, high density lipoprotein cholesterol (HDL-C), a protective factor, is higher in women than in men.
T he large preponderance for coronary heart disease in men is well recognized. At least some of the sex differential has been attributed to differences in cardiovascular risk factor levels; notably, high density lipoprotein cholesterol (HDL-C), a protective factor, is higher in women than in men. 12 Sex differences in lipid and lipoprotein levels have been postulated to be related to hormonal differences. Exogenous estrogen is associated with increased HDL-C in women, 3 and high doses of estrogens administered to men for treatment result in an increase in HDL-C. 4 - 5 In men, exogenous testosterone decreases HDL-C. 67 In adolescent males, puberty and increasing testosterone levels are associated with decreasing levels of HDL-C. 89 However, the relation between endogenous androgens and lipid levels is more controversial, and most studies have reported a positive relation between testosterone levels and HDL-C in adult men 10 - 21 -a finding inconsistent with the associations of coronary heart disease with low HDL-C levels and male gender. We investigated the relation between endogenous sex hormones and lipid levels in a large population-based sample of adult men aged 30-79 years.
Methods
Between 1972 and 1974, 82% of Caucasian adults aged 30-79 years who lived in a geographically defined community (Rancho Bernardo) in southern California 22 participated in a survey of cardiovascular disease risk factors. Plasma for the sex hormone assays was obtained by venipuncture between 7:30 and 11 AM from fasting subjects and was frozen at -70°C. A 30% sample of men was selected for a second visit approximately 100 days later. This sample comprised a 15% random sample and an equal proportion (15%) with hyperlipidemia; the latter represented those in the top 10% of the cholesterol or top 5% of the triglyceride distribution. At this visit, a medical history was obtained, which included questions about cigarette smoking habit, regular exercise, alcohol intake in the past week, and current medications. (Responses to these questions were later indirectly validated by showing the expected correlates with other attributes, e.g., smoking and HDL, alcohol and serum aspartate aminotransferase, Variation from CDC-supplied "unknowns" is less than 1% for serum cholesterol and LDL-C and less than 5% for HDL-C and triglycerides.
In 1984-1986, specimens were thawed for sex hormone radioimmunoassays in an endocrinology research laboratory. 2324 Previous work in the laboratory (S.S. Yen, personal communication) and elsewhere 25 has demonstrated no hormone deterioration over 15 years when sera have been frozen and stored in tightly sealed containers. The sensitivity and intraassay and interassay coefficients of variation, respectively, were 0.02 /imol/1, 5%, and 10% for dehydroepiandrosterone sulfate (DHEAS); 30 nmol/1, 4%, and 8% for androstenedione; 7 pmol/1, 15%, and 16% for estrone; and 5 pmol/1, 8%, and 12% for estradiol. Sex hormone-binding globulin (SHBG) was determined by the method of Rosner. 26 Samples for the sex hormone assay were selected based solely on availability of plasma without knowledge of lipid and lipoprotein values. Frozen plasma samples from men aged 30-79 years at visit 1 in 1972-1974 who also had data on lipid levels from visit 2 were selected up to the number permitted by budget constraints.
All statistical analyses were performed using the Statistical Package for Social Sciences (SPSSX, MJ. Norusis, SPSS Inc., Chicago, 111.). Adjustments for age and for age and body mass index were made using an analysis of variance. Multiple regression was used to adjust for other attributes associated with lipid levels. All analyses were also performed using logarithmic values for the hormone levels to account for the slight skew in distribution. Because the results were similar, results of logarithmic analyses are not shown. All probability values are based on two-tailed tests. No adjustment was made for multiple comparisons.
Results
There were 366 men aged 30-79 years from visit 2 who had hormone assays from the visit 1 plasma samples. These men did not differ significantly by age or mean lipid levels from those without assays.
Total cholesterol (r=0.07, p=0.97) and LDL-C (r=0.04, p=0.22) were not significantly related to age, but HDL-C increased (r=0.23, /?<0.001) and very low density lipoprotein cholesterol (VLDL-C) decreased (r=-0.14, p<0.01) with increasing age. DHEAS (r=-0.57, /?<0.001), androstenedione (r=-0.32, /><0.001), and testosterone (r=-0.08, p=Q.O7) decreased with age, while estrone (r=0.20, p<0.001) and SHBG (r=0.27, /?<0.001) increased with age. Estradiol was not significantly age related (r= -0.04,^=0.23). Age-adjusted HDL-C was negatively (r=-0.17, /><0.001) and total cholesterol (r=0.07, p=0.08) and VLDL-C (r=0.22, /?<0.001) were positively associated with body mass index; LDL-C (r=0.03, p=0.27) was not related to body mass index. Age-adjusted DHEAS (r=-0.11, p<0.05), androstenedione (r=0.12, p<0.05), testosterone (r=-0.25, p<0.01), and SHBG (r=-0.18, /?<0.001) were all negatively related to body mass index; age-adjusted estrone (r=0.09, p=0.05) and estradiol (r=0.07, p=0.09) were weakly positively related to body mass index. Table 1 shows mean crude, age-adjusted, and age and body mass index-adjusted hormone and SHBG levels according to the category of lipid level using clinically determined cutpoints. Mean androstenedione, estrone, and estradiol levels were significantly higher in men with cholesterol levels of 6.2 mmol/1 (240 mg/dl) or greater, as well as in men with LDL levels of 4.2 mmol/1 (160 mg/dl) or greater. Mean testosterone levels were significantly lower in men with HDL-C levels less than 1 mmol/l (40 mg/dl) or in men with VLDL-C levels greater than 0.5 mmol/1 (20 mg/dl). Estrone levels were also significantly higher and SHBG lower in men with VLDL-C levels greater than 0.05 mmol/1 (20 mg/dl). DHEAS values were not significantly related to any lipid levels. Table 2 shows age and body mass index-adjusted mean lipid levels by quartile of hormone and SHBG level. Androstenedione and estrone were significantly positively correlated with total cholesterol, LDL-C, and VLDL-C, and estradiol was correlated with LDL-C. Testosterone was positively related to HDL-C and negatively related to VLDL-C. These associations were essentially unchanged after further adjustment for current cigarette smoking, alcohol intake, and reported physical exercise (data not shown).
Discussion
In this cohort, endogenous estrogens and androstenedione were associated with adverse lipid risk profiles, while testosterone was associated with favorable levels. The positive relation between testosterone and HDL-C is consistent with nine of 12 other studies of middle-aged men as shown in Table 3. 10 "
21
Correlation coefficients in the studies showing a statistically significant positive association ranged from 0.11 14 to 0.65. 19 Only two studies examined HDL subtractions: Miller et al 18 found no association with total HDL-C but a significant (r not given; p<0.01) positive association with HDL2 that persisted after adjusting for weight, alcohol intake, and cigarette smoking, and Stefanick et al 20 reported no statistically significant association with HDL2 (r=0.04) but a significant negative correlation with HDL, (r=-0.24, p<0.05) that disappeared after •p<0.05, tp<0.01.
high density lipoprotein; LDL, low density lipoprotein; VLDL, very low density adjusting for smoking, alcohol intake, and percent body fat (r=-0.05). Inconsistencies may in part be explained by true differences in the individuals studied and by problems of confounding. None of the articles cited in Table 3 were based on men selected because they had survived a myocardial infarction or had been referred for coronary angjography, since postdisease behavior and treatment may change prior associations. Confounding is difficult to address when-as in the case with HDL-C-several other attributes such as cigarette smoking, alcohol use, exercise, and obesity are also strong determinants of lipid levels. 20 - 21 Failure to consider these variables in univariate analysis may not reveal a real association that is obscured by such attributes. Alternatively, if attributes are biologically related to a testosterone-HDL association, then adjusting for them could mask a clinically important association. For example, if levels of plasma testosterone cause weight gain and central obesity, which in turn lower HDL, then controlling for obesity, percent body fat, and/or central fat would be inappropriate. Adjusting for other sex hormones is likewise potentially misleading without knowing the pathways involved.
We considered other possible explanations for the divergent results. The present study, like most previous studies, was dependent on only a single plasma sample with which to characterize individuals with respect to hormone and lipid levels. (Blood was obtained from fasting subjects in the morning, thus reducing some sources of variation that may have plagued other studies.) Furthermore, blood for hormone and lipid measurements was not obtained concurrently but approximately 100 days apart. Nevertheless, significant associations were demonstrable. Random measurement error is likely to reduce the chances of finding any associations, not produce one. This, together with the consistency of our results with most previous studies, suggests that the positive relation of testosterone with HDL-C and the negative relation with VLDL-C is not spurious. The mechanisms for the observed associations are not known. Although it has been documented that gonadal hormones influence blood and tissue lipids, most studies have been based on exogenous hormone administration of different formulations and varying doses. Even so, the effects of exogenous androgens on lipid metabolism are poorly understood. While low dosages have been associated with hypolipemic response, high doses have had opposite effects. 27 - 28 It has been suggested that adrogens may have a primary inhibitory effect on the synthesis of apolipoprotein A, the main apolipoprotein in HDL, and a stimulating effect on lipoprotein lipase activity.
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- 30 The dissociation of effects between different androgenic hormones observed in our study raises questions and may explain some inconsistencies in previous studies: androstenedione, predominantly of adrenal origin, is adversely related to lipid risk profiles, while testosterone, a gonadal androgen, is favorably related. Several pathways can be postulated. Testosterone may directly relate to HDL levels, perhaps by enzyme induction. Alternatively, the relation of testosterone to lipids may be due to peripheral conversion to estradiol. However, in this study, estrogens were in fact adversely related to lipid levels. Third, hormone and lipid levels may simply both be markers of altered metabolic pathways: hepatic metabolism or interconversion of hormones, and synthesis or degradation of cholesterol.
Whatever the mechanism, the excess risk of cardiovascular disease in men seems unlikely to be attributed to high levels of testosterone per se, the predominant male gonadaJ hormone. What evidence there is suggests that testosterone levels in men are in fact beneficially associated not only with lipid levels but also with other cardiovascular risk factors including fasting plasma glucose 31 and blood pressure 32 and possibly beneficially associated with cardiovascular outcome, 33 -34 whereas estrogen levels have the converse relation with lipids in men. These results point to the need for a better understanding of the differing effects and interactions of specific endogenous sex hormones in each sex.
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